Genomics

Dataset Information

In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma


ABSTRACT: In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma

PROVIDER: PRJNA576429 | ENA |

REPOSITORIES: ENA